Icariside I

Cat. No.: OB0225WX-2217

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Icariside I is a flavonol glycoside isolated from the Epimedium herb that modulates bone metabolism by inhibiting osteoclast resorption and promoting BMSC differentiation.

Synonym: Lcariside I; Icariin I; Icarisid I; 56725-99-6; Baohuoside-1; 3,5-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; 3,5-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one; Anhydroicaritin-7-O-glucoside; IcarisideI; Icariside-I; icariside 1; 3,5,7-Trihydroxy-4'-methoxy-8'-prenylflavone-3-O-alpha-L-rhamnopranoxide; 4H-1-Benzopyran-4-one, 3,5-dihydroxy-7-(beta-D-glucopyranosyloxy)-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-

CAS No.: 56725-99-6

Compound CID: 5745470

Formula: C₂₇H₃₀O₁₁

Formula Weight: 530.52

Specification

Relative Density: 1.475 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Icariside I is applied in traditional medicine and bone research as a bioactive flavonoid to study its role in promoting osteoblast differentiation and its protective effects against oxidative stress.